{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:52:28Z","timestamp":1793393548261,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ajem.2022.01.011","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T02:21:13Z","timestamp":1642126873000},"page":"180-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Emergency medicine updates: Droperidol"],"prefix":"10.1016","volume":"53","author":[{"given":"David","family":"Cisewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajem.2022.01.011_bb0005","first-page":"53","article-title":"Droperidol interacts with vascular serotonin receptors and alpha-adrenoceptors","volume":"330","author":"Castillo","year":"1995","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"4","key":"10.1016\/j.ajem.2022.01.011_bb0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jemermed.2010.07.005","article-title":"Droperidol analgesia for opioid-tolerant patients","volume":"41","author":"Richards","year":"2011","journal-title":"J Emerg Med"},{"issue":"12","key":"10.1016\/j.ajem.2022.01.011_bb0015","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1176\/ajp.137.12.1518","article-title":"Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency","volume":"137","author":"Peroutka","year":"1980","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.ajem.2022.01.011_bb0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00000542-197304000-00010","article-title":"Absorption, metabolism and excretion of droperidol by human subjects following intramuscular and intravenous administration","volume":"38","author":"Cressman","year":"1973","journal-title":"Anesthesiology."},{"key":"10.1016\/j.ajem.2022.01.011_bb0025","author":"American Regent"},{"issue":"1","key":"10.1016\/j.ajem.2022.01.011_bb0030","first-page":"121","article-title":"Nausea and vomiting in pregnancy","volume":"68","author":"Quinlan","year":"2003","journal-title":"AFP."},{"issue":"11","key":"10.1016\/j.ajem.2022.01.011_bb0035","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2146\/ajhp060505","article-title":"Evidence-based review of the black-box warning for droperidol","volume":"64","author":"Jackson","year":"2007","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.ajem.2022.01.011_bb0040","first-page":"1","article-title":"Evidence-based review and appraisal of the use of droperidol in the emergency department","volume":"30","author":"Lai","year":"2018","journal-title":"Ci Ji Yi Xue Za Zhi"},{"issue":"6","key":"10.1016\/j.ajem.2022.01.011_bb0050","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/ajhp\/59.6.494","article-title":"Black-box warning for droperidol surprises pharmacists","volume":"59","author":"Young","year":"2002","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"10.1016\/j.ajem.2022.01.011_bb0055","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1213\/01.ANE.0000121199.16379.A0","article-title":"\u201cBlack box\u201d warning on droperidol: report of the FDA convened expert panel","volume":"98","author":"Gan","year":"2004","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.ajem.2022.01.011_bb0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.annemergmed.2003.05.006","article-title":"Droperidol and the black box warning","volume":"43","author":"van Zwieten","year":"2004","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2022.01.011_bb0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.annemergmed.2015.05.030","article-title":"Training the mind, and the Food and Drug Administration, on Droperidol","volume":"66","author":"Newman","year":"2015","journal-title":"Ann Emerg Med"},{"issue":"4","key":"10.1016\/j.ajem.2022.01.011_bb0070","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1213\/00000539-200210000-00001","article-title":"Droperidol: a cost-effective antiemetic for over thirty years","volume":"95","author":"White","year":"2002","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.ajem.2022.01.011_bb0075","first-page":"731","article-title":"A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 study groups","volume":"86","author":"Fortney","year":"1998","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.ajem.2022.01.011_bb0080","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5114\/aoms.2015.50968","article-title":"Ondansetron-droperidol combination vs. ondansetron or droperidol monotherapy in the prevention of postoperative nausea and vomiting","volume":"11","author":"Matsota","year":"2015","journal-title":"Arch Med Sci"},{"issue":"2","key":"10.1016\/j.ajem.2022.01.011_bb0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajem.2005.08.017","article-title":"Antiemetics in the ED: a randomized controlled trial comparing 3 common agents","volume":"24","author":"Braude","year":"2006","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2022.01.011_bb0090","article-title":"Drugs for the treatment of nausea and vomiting in adults in the emergency department setting","volume":"9","author":"Furyk","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ajem.2022.01.011_bb0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/01.WNL.0000042477.63516.B2","article-title":"Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial","volume":"60","author":"Silberstein","year":"2003","journal-title":"Neurology."},{"issue":"9","key":"10.1016\/j.ajem.2022.01.011_bb0100","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1553-2712.2001.tb01147.x","article-title":"Droperidol vs. prochlorperazine for benign headaches in the emergency department","volume":"8","author":"Miner","year":"2001","journal-title":"Acad Emerg Med"},{"issue":"2","key":"10.1016\/j.ajem.2022.01.011_bb0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jemermed.2003.05.005","article-title":"Droperidol vs prochlorperazine for the treatment of acute headache","volume":"26","author":"Weaver","year":"2004","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2022.01.011_bb0110","author":"Faine"},{"issue":"3","key":"10.1016\/j.ajem.2022.01.011_bb0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1192\/bjp.bp.114.150227","article-title":"Droperidol v. haloperidol for sedation of aggressive behaviour in acute mental health: randomised controlled trial","volume":"206","author":"Calver","year":"2015","journal-title":"Br J Psychiatry"},{"issue":"4","key":"10.1016\/j.ajem.2022.01.011_bb0120","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0196-0644(05)82660-5","article-title":"Droperidol versus haloperidol for chemical restraint of agitated and combative patients","volume":"21","author":"Thomas","year":"1992","journal-title":"Ann Emerg Med"},{"issue":"4","key":"10.1016\/j.ajem.2022.01.011_bb0125","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.annemergmed.2010.05.037","article-title":"Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study","volume":"56","author":"Isbister","year":"2010","journal-title":"Ann Emerg Med"},{"issue":"2","key":"10.1016\/j.ajem.2022.01.011_bb0130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.annemergmed.2021.01.005","article-title":"A prospective study of intramuscular Droperidol or olanzapine for acute agitation in the emergency department: a natural experiment owing to drug shortages","volume":"78","author":"Cole","year":"2021","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2022.01.011_bb0135","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.annemergmed.2016.07.033","article-title":"Midazolam-droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial","volume":"69","author":"Taylor","year":"2017","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.ajem.2022.01.011_bb0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0735-6757(99)90037-2","article-title":"Droperidol for the treatment of acute peripheral vertigo","volume":"17","author":"Irving","year":"1999","journal-title":"Am J Emerg Med"},{"issue":"6","key":"10.1016\/j.ajem.2022.01.011_bb0145","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1197\/aemj.9.6.650","article-title":"Intramuscular droperidol versus intramuscular dimenhydrinate for the treatment of acute peripheral vertigo in the emergency department: a randomized clinical trial","volume":"9","author":"Irving","year":"2002","journal-title":"Acad Emerg Med"},{"issue":"9","key":"10.1016\/j.ajem.2022.01.011_bb0150","first-page":"541","article-title":"Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol","volume":"40","author":"Guy","year":"1991","journal-title":"Ann Cardiol Angeiol"},{"issue":"5","key":"10.1016\/j.ajem.2022.01.011_bb0155","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1213\/00000539-199411000-00028","article-title":"Droperidol causes a dose-dependent prolongation of the QT interval","volume":"79","author":"Lischke","year":"1994","journal-title":"Anesth Analg"},{"issue":"7","key":"10.1016\/j.ajem.2022.01.011_bb0160","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.gie.2006.01.052","article-title":"Droperidol, when used for sedation during ERCP, may prolong the QT interval","volume":"63","author":"Yimcharoen","year":"2006","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"10.1016\/j.ajem.2022.01.011_bb0165","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jemermed.2018.12.036","article-title":"Rescue sedation when treating acute agitation in the emergency department with intramuscular antipsychotics","volume":"56","author":"Klein","year":"2019","journal-title":"J Emerg Med"},{"issue":"7","key":"10.1016\/j.ajem.2022.01.011_bb0170","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ajem.2019.09.007","article-title":"Effectiveness and safety of droperidol in a United States emergency department","volume":"38","author":"Gaw","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"5","key":"10.1016\/j.ajem.2022.01.011_bb0175","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/bcp.12272","article-title":"High dose droperidol and QT prolongation: analysis of continuous 12-lead recordings","volume":"77","author":"Calver","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.ajem.2022.01.011_bb0180","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/00000542-200506000-00006","article-title":"Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron","volume":"102","author":"Charbit","year":"2005","journal-title":"Anesthesiology."},{"issue":"16","key":"10.1016\/j.ajem.2022.01.011_bb0185","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.289.16.2120","article-title":"What clinicians should know about the QT interval","volume":"289","author":"Al-Khatib","year":"2003","journal-title":"JAMA."},{"issue":"13","key":"10.1016\/j.ajem.2022.01.011_bb0190","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2015.12.063","article-title":"Predicting the unpredictable: drug-induced QT prolongation and Torsades de pointes","volume":"67","author":"Schwartz","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajem.2022.01.011_bb0195","series-title":"Electrocardiography in emergency, acute, and critical care","author":"Mattu","year":"2019"},{"issue":"1","key":"10.1016\/j.ajem.2022.01.011_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jemermed.2014.12.024","article-title":"American Academy of emergency medicine position statement: safety of Droperidol use in the emergency department","volume":"49","author":"Perkins","year":"2015","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2022.01.011_bb0205","author":"ACEP"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722000158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722000158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:59:17Z","timestamp":1760025557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675722000158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":40,"alternative-id":["S0735675722000158"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2022.01.011","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergency medicine updates: Droperidol","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2022.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}